4
Changes in Ownership
Acumen Pharmaceuticals, Inc. Filed Acc 0001209191-21-046028
10% owner bought 312,500 shares at $16.00 ($5,000,000)
- 10% owner acquired 3,608,469 shares (conversion)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Hardie Robert D. 10% owner | 2021-07-06 | Conversion | +2,950,484 | 3,040,193 | I | ||
| Hardie Robert D. 10% owner | 2021-07-06 | Purchase | +312,500 | $16.00 | $5,000,000 | 3,352,693 | I |
| Hardie Robert D. 10% owner | 2021-07-06 | Conversion | +657,985 | 657,985 | I | ||
| Derivatives | |||||||
| Hardie Robert D. 10% owner | 2021-07-06 | Conversion · Series A-1 Preferred Stock | −1,634,515 | 0 | I | ||
| Hardie Robert D. 10% owner | 2021-07-06 | Conversion · Series B Preferred Stock | −1,315,969 | 0 | I | ||
| Hardie Robert D. 10% owner | 2021-07-06 | Conversion · Series B Preferred Stock | −657,985 | 0 | I | ||
| Open-market purchases · 312,500 sh · avg $16.00 · $5,000,000 | |||||||
Loading xslF345X03/doc4.xml…